[Anti-tuberculosis drugs].
Doi
Norio
N
Department of Basic Research, Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association.
D042462:4-Quinolones; D000890:Anti-Infective Agents; D000995:Antitubercular Agents / Q000145:classification / Q000494:pharmacology; D002746:Chlorpromazine / Q000031:analogs & derivatives* / Q000494:pharmacology; D016503:Drug Delivery Systems; D015195:Drug Design; D024901:Drug Resistance, Multiple, Bacterial / Q000235:genetics; D006801:Humans; D009169:Mycobacterium tuberculosis / Q000187:drug effects; D009593:Nitroimidazoles / Q000494:pharmacology; D012294:Rifamycins / Q000494:pharmacology
D042462:4-Quinolones; D000890:Anti-Infective Agents; D000995:Antitubercular Agents; D009593:Nitroimidazoles; D012294:Rifamycins; C410767:pretomanid; C068980:KRM 1648; C054383:N-benzoyloxymethylchlorpromazine; D002746:Chlorpromazine